Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7775.T Stock Summary
Top 10 Correlated ETFs
7775.T
In the News
7775.T Financial details
Company Rating
Strong Buy
Market Cap
15.71B
Income
754.5M
Revenue
9.3B
Book val./share
227.24
Cash/share
86.63
Dividend
20
Dividend %
3.77%
Employees
188
Optionable
No
Shortable
Yes
Earnings
30 Oct 2023
P/E
20.22
Forward P/E
-
PEG
-21.99
P/S
1.64
P/B
2.34
P/C
6.13
P/FCF
-
Quick Ratio
1.05
Current Ratio
1.87
Debt / Equity
0.42
LT Debt / Equity
0.14
-
-
EPS (TTM)
26.27
EPS next Y
-
EPS next Q
-
EPS this Y
-14.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.12%
Revenue last 5Y
1.68%
Revenue Q/Q
5.4%
EPS Q/Q
914.29%
-
-
-
-
SMA20
0.56%
SMA50
6.79%
SMA100
10.18%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
11%
ROC
0.15%
Gross Margin
38%
Oper. Margin
12%
Profit Margin
8%
Payout
-
Shs Outstand
28.73M
Shs Float
13.41M
-
-
-
-
Target Price
-
52W Range
440.0-565.0
52W High
-6.02%
52W Low
+20.68%
RSI
38.48
Rel Volume
0.56
Avg Volume
47.1K
Volume
26.3K
Perf Week
-2.57%
Perf Month
-1.12%
Perf Quarter
12.03%
Perf Half Y
7.93%
-
-
-
-
Beta
0.144587
-
-
Volatility
5.75%, 9.1%
Prev Close
-1.12%
Price
531
Change
-0.56%
7775.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 286.78 | 296.69 | 273.67 | 297.28 | 318.05 | |
Net income per share | 29.05 | 29.92 | 23.5 | 28.93 | 24.79 | |
Operating cash flow per share | 30.05 | 50.02 | 21.2 | 39.46 | 34.43 | |
Free cash flow per share | 22.98 | 44.13 | 10.34 | 32.39 | 27.5 | |
Cash per share | 71.71 | 79.86 | 73.14 | 87.67 | 85.24 | |
Book value per share | 196.77 | 211.69 | 215.2 | 224.38 | 229.64 | |
Tangible book value per share | 195.67 | 210.67 | 214.44 | 223.85 | 229.31 | |
Share holders equity per share | 196.77 | 211.69 | 215.2 | 224.38 | 229.64 | |
Interest debt per share | 117.86 | 101.77 | 103.01 | 101.81 | 94.81 | |
Market cap | 16.33B | 18.87B | 17.5B | 14.65B | 13.82B | |
Enterprise value | 17.56B | 19.43B | 18.28B | 15.05B | 14.02B | |
P/E ratio | 19.17 | 21.96 | 25.91 | 17.63 | 19.41 | |
Price to sales ratio | 1.94 | 2.21 | 2.23 | 1.72 | 1.51 | |
POCF ratio | 18.53 | 13.14 | 28.72 | 12.92 | 13.97 | |
PFCF ratio | 24.23 | 14.89 | 58.88 | 15.75 | 17.49 | |
P/B Ratio | 2.83 | 3.1 | 2.83 | 2.27 | 2.09 | |
PTB ratio | 2.83 | 3.1 | 2.83 | 2.27 | 2.09 | |
EV to sales | 2.09 | 2.28 | 2.33 | 1.76 | 1.53 | |
Enterprise value over EBITDA | 11.3 | 13.24 | 15.01 | 10.24 | 10.58 | |
EV to operating cash flow | 19.93 | 13.52 | 30.01 | 13.28 | 14.18 | |
EV to free cash flow | 26.06 | 15.33 | 61.52 | 16.18 | 17.75 | |
Earnings yield | 0.05 | 0.05 | 0.04 | 0.06 | 0.05 | |
Free cash flow yield | 0.04 | 0.07 | 0.02 | 0.06 | 0.06 | |
Debt to equity | 0.6 | 0.48 | 0.48 | 0.45 | 0.41 | |
Debt to assets | 0.31 | 0.27 | 0.27 | 0.27 | 0.25 | |
Net debt to EBITDA | 0.79 | 0.38 | 0.64 | 0.27 | 0.15 | |
Current ratio | 1.71 | 1.69 | 1.87 | 2.09 | 1.97 | |
Interest coverage | 262.3 | 262.45 | 241.98 | 307.97 | 265.94 | |
Income quality | 0.76 | 1.21 | 0.64 | 0.98 | 0.97 | |
Dividend Yield | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | |
Payout ratio | 0.91 | 0.64 | 0.85 | 0.69 | 0.79 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.24 | -0.12 | -0.51 | -0.18 | -0.2 | |
Capex to revenue | -0.02 | -0.02 | -0.04 | -0.02 | -0.02 | |
Capex to depreciation | -0.68 | -0.67 | -1.22 | -0.65 | -0.74 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 358.63 | 377.51 | 337.35 | 382.16 | 357.86 | |
ROIC | 0.1 | 0.1 | 0.07 | 0.09 | 0.08 | |
Return on tangible assets | 0.08 | 0.08 | 0.06 | 0.08 | 0.06 | |
Graham Net | -13.33 | -20.64 | -18.9 | -5.55 | -7.66 | |
Working capital | 2.64B | 2.62B | 2.93B | 3.42B | 3.27B | |
Tangible asset value | 5.74B | 6.05B | 6.16B | 6.43B | 6.59B | |
Net current asset value | 1.14B | 1.49B | 1.7B | 2.1B | 2.22B | |
Invested capital | 0.6 | 0.48 | 0.48 | 0.45 | 0.41 | |
Average receivables | 2.78B | 2.27B | 1.77B | 1.49B | 1.34B | |
Average payables | 883.16M | 901.64M | 891.41M | 636.77M | 493.19M | |
Average inventory | 1.37B | 1.34B | 1.3B | 1.48B | 1.53B | |
Days sales outstanding | 113.48 | 82.34 | 75.25 | 58.38 | 52.72 | |
Days payables outstanding | 68.35 | 73.65 | 66.17 | 34.36 | 34.45 | |
Days of inventory on hand | 122.51 | 89.42 | 115.26 | 116.08 | 98.6 | |
Receivables turnover | 3.22 | 4.43 | 4.85 | 6.25 | 6.92 | |
Payables turnover | 5.34 | 4.96 | 5.52 | 10.62 | 10.6 | |
Inventory turnover | 2.98 | 4.08 | 3.17 | 3.14 | 3.7 | |
ROE | 0.15 | 0.14 | 0.11 | 0.13 | 0.11 | |
Capex per share | -7.07 | -5.89 | -10.86 | -7.07 | -6.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 76.46 | 78.61 | 84.99 | 78 | 82.21 | |
Net income per share | 7.04 | 7.9 | 9.01 | 0.83 | 8.52 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 81.16 | 79.45 | 72.15 | 85.24 | 86.63 | |
Book value per share | 220.55 | 228.57 | 228.69 | 229.64 | 227.24 | |
Tangible book value per share | 220.55 | 228.57 | 228.69 | 229.31 | 227.24 | |
Share holders equity per share | 220.55 | 228.57 | 228.69 | 229.64 | 227.24 | |
Interest debt per share | 100.31 | 94.35 | 89.96 | 94.71 | 96.06 | |
Market cap | 13.99B | 13.39B | 12.9B | 13.82B | 15.05B | |
Enterprise value | 14.54B | 13.81B | 13.41B | 14.02B | 15.32B | |
P/E ratio | 17.29 | 14.75 | 12.46 | 144.33 | 15.38 | |
Price to sales ratio | 6.37 | 5.93 | 5.28 | 6.17 | 6.37 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 2.21 | 2.04 | 1.96 | 2.09 | 2.31 | |
PTB ratio | 2.21 | 2.04 | 1.96 | 2.09 | 2.31 | |
EV to sales | 6.62 | 6.12 | 5.49 | 6.26 | 6.49 | |
Enterprise value over EBITDA | 50.29 | 43.46 | 36.76 | 163.48 | 44.66 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0 | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.45 | 0.41 | 0.39 | 0.41 | 0.42 | |
Debt to assets | 0.27 | 0.25 | 0.24 | 0.25 | 0.25 | |
Net debt to EBITDA | 1.9 | 1.34 | 1.4 | 2.37 | 0.79 | |
Current ratio | 2.02 | 2.08 | 1.88 | 1.97 | 1.87 | |
Interest coverage | 294.49 | 319.24 | 384.33 | 81.06 | 281.47 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 186.94 | 201.56 | 215.32 | 65.61 | 208.72 | |
ROIC | 0.02 | 0.02 | 0.03 | 0 | 0.03 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0 | 0.02 | |
Graham Net | -10.77 | -7.33 | -10.85 | -7.66 | -9.63 | |
Working capital | 3.26B | 3.38B | 3.09B | 3.27B | 3.09B | |
Tangible asset value | 6.32B | 6.55B | 6.56B | 6.59B | 6.52B | |
Net current asset value | 2.03B | 2.26B | 2.26B | 2.22B | 2.17B | |
Invested capital | 0.45 | 0.41 | 0.39 | 0.41 | 0.42 | |
Average receivables | 1.35B | 1.3B | 1.37B | 1.39B | 1.29B | |
Average payables | 454.05M | 457.45M | 495.88M | 528.49M | 529.69M | |
Average inventory | 1.56B | 1.61B | 1.66B | 1.59B | 1.54B | |
Days sales outstanding | 54.47 | 50.65 | 53.99 | 53.01 | 47.98 | |
Days payables outstanding | 31.65 | 31.37 | 32.93 | 30.7 | 33.99 | |
Days of inventory on hand | 110.07 | 111.88 | 104.39 | 87.88 | 100.5 | |
Receivables turnover | 1.65 | 1.78 | 1.67 | 1.7 | 1.88 | |
Payables turnover | 2.84 | 2.87 | 2.73 | 2.93 | 2.65 | |
Inventory turnover | 0.82 | 0.8 | 0.86 | 1.02 | 0.9 | |
ROE | 0.03 | 0.03 | 0.04 | 0 | 0.04 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
7775.T Frequently Asked Questions
What is Daiken Medical Co., Ltd. stock symbol ?
Daiken Medical Co., Ltd. is a JP stock and trading under the symbol 7775.T
What is Daiken Medical Co., Ltd. stock quote today ?
Daiken Medical Co., Ltd. stock price is $531 today.
Is Daiken Medical Co., Ltd. stock public?
Yes, Daiken Medical Co., Ltd. is a publicly traded company.